SENNA- senna tablet, coated 
NCS HealthCare of KY, Inc dba Vangard Labs

Disclaimer: Most OTC drugs are not reviewed and approved by FDA, however they may be marketed if they comply with applicable regulations and policies. FDA has not evaluated whether this product complies.

----------

Senna Tabs sennosides

Active Ingredient (in each tablet)

Sennosides 8.6 mg 

Purpose

 Laxative

Uses     

•     relieves occasional constipation (Irregularity)

•     Generally causes bowel movement in 6-12 hours

Warnings

Do not use

•  laxative products for longer than 1 week unless directed by a doctor

Ask a doctor before use if you have

• stomach pain

• nausea

• vomiting

• noticed a sudden change in bowel movements that continues over a period of 2 weeks

Stop use and ask a doctor if

 you have rectal bleeding or fail to have a bowel movement after use of a laxative. These may indicate a serious condition.

​

If pregnant or breast-feeding, ask a health professional before use.

​

Keep out of reach of children. In case of overdose, get medical help or contact a Poison Control Center right away.

Directions

• take preferably at bedtime or as directed by a doctor

• If you do not have a comfortable bowel movement by the second day, increase dose by one tablet (do not exceed maximum dosage) or decrease dose until you are comfortable

age starting dosagemaximum dosage
adults and children over 12 years 2 tablets once a day 4 tablets twice a day
children 6 to under 12 years 1 tablet once a day 2 tablets twice a day
children 2 to under 6 years 1/2 tablet once a day 1 tablet twice a day
children under 2 years ask a doctor ask a doctor

Other information

• each tablet contains: calcium 25 mg, sodium 2 mg. VERY LOW SODIUM

• TAMPER EVIDENT: DO NOT USE THIS PRODUCT IF THE IMPRINTED FOIL SEAL OVER THE MOUTH OF THE BOTTLE IS CUT, TORN, BROKEN OR MISSING

• store at 25ºC (77ºF); excursions permitted between 15º-30ºC (59º-86ºF)

Inactive Ingredients

croscarmellose sodium, dibasic calcium phosphate dihydrate, hypromellose, magnesium stearate, microcrystalline cellulose, mineral oil 

Questions or comments?  (800) 616-2471

Distributed by MAJOR® PHARMACEUTICALS  

                       31778 Enterprise Drive

                        Livonia, MI  48150

                        M-14               Rev. 03/15

Principal Display Panel

 Senna Tabs (Sennosides) 8.6 mg

SENNA 
senna tablet, coated
Product Information
Product TypeHUMAN OTC DRUGItem Code (Source)NDC:0615-7923(NDC:0904-6434)
Route of AdministrationORAL
Active Ingredient/Active Moiety
Ingredient NameBasis of StrengthStrength
SENNOSIDES A AND B (UNII: 1B5FPI42EN) (SENNOSIDES A AND B - UNII:1B5FPI42EN) SENNOSIDES A AND B8.6 mg
Inactive Ingredients
Ingredient NameStrength
CROSCARMELLOSE SODIUM (UNII: M28OL1HH48)  
CALCIUM PHOSPHATE, DIBASIC, DIHYDRATE (UNII: O7TSZ97GEP)  
HYPROMELLOSES (UNII: 3NXW29V3WO)  
MAGNESIUM STEARATE (UNII: 70097M6I30)  
CELLULOSE, MICROCRYSTALLINE (UNII: OP1R32D61U)  
MINERAL OIL (UNII: T5L8T28FGP)  
Product Characteristics
ColorBROWNScoreno score
ShapeROUNDSize9mm
FlavorImprint Code TCL080
Contains    
Packaging
#Item CodePackage DescriptionMarketing Start DateMarketing End Date
1NDC:0615-7923-3930 in 1 BLISTER PACK; Type 0: Not a Combination Product08/31/201508/31/2020
Marketing Information
Marketing CategoryApplication Number or Monograph CitationMarketing Start DateMarketing End Date
OTC MONOGRAPH NOT FINALpart33406/09/201508/31/2020
Labeler - NCS HealthCare of KY, Inc dba Vangard Labs (050052943)
Establishment
NameAddressID/FEIBusiness Operations
NCS HealthCare of KY, Inc dba Vangard Labs050052943REPACK(0615-7923)

Revised: 9/2015
Document Id: 6bfae50e-c1d0-4dd6-a883-911b5ffeed0d
Set id: 3aa7537e-b721-45f9-b828-7c7031eda270
Version: 3
Effective Time: 20150911
 
NCS HealthCare of KY, Inc dba Vangard Labs